Brief: RenovoRx Says As Of Sept 30, Co Had Cash, Cash Equivalents Of $17.7 Mln And No Outstanding Debt Obligations
Nov 15 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS
* RENOVORX INC - AS OF SEPT 30, 2021, CO HAD CASH, CASH
EQUIVALENTS OF $17.7 MILLION AND NO OUTSTANDING DEBT OBLIGATIONS
Source text for Eikon: ID:nBw5vBCgma
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies